Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05777473 · ClinicalTrials.gov registry record · NA

Tipping Point: Using Social Network Theory to Accelerate Scale and Impact

A NA study of Contraception, sponsored by University of California, San Diego.

Active
Registry status
NA
Development phase
3,825
Enrollment target
1
Study location

NCT05777473: Active NA study of Contraception, sponsored by University of California, San Diego.

NCT05777473 is a NA study of Contraception that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 3,825 participants, above the 402-participant average among 72 other Contraception trials with a reported enrollment target (851% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05777473, a NA study of Contraception, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,825 participants
Enrollment target
1
Study location

Study Summary

This study will assess the nature and impact of social norms and networks to promote FP (Family Planning) intervention effects among low parity, married adolescent and young women in the Maradi region of Niger. Research activities will be layered on top of the USAID-funded Kulawa FP program that seeks to change FP-related behaviors among young, low parity women at scale in Niger in a subset of implementing villages. Kulawa, implemented by Save the Children U.S. (SCUS) and funded by USAID (2020-2025), will include small-group discussion for young, low parity girls coupled with community dialogues to address individual, social, and health system constraints to FP use and influence social norms that govern FP use. UCSD will not provide any services or implement any interventions as part of this study.

Conditions Studied

Interventions

  • BEHAVIORAL Household Visits
  • BEHAVIORAL Small Groups
  • BEHAVIORAL Adopt-a-Friend

Study Locations (1)

California

  • Center on Gender Equity and Health, University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 3,825 participants
Start Date 2020-12-01
Est. Completion 2025-05-01
Phase NA
University of California, San Diego

775 total trials

What the registry record for NCT05777473 still lists

NCT05777473 is an interventional study that assigns participants to a tested intervention. Its 3,825 participants enrollment target places it among the larger protocols in the corpus, above the 402-participant average among 72 other Contraception trials with a reported enrollment target (851% higher).

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 3 interventions - of which Household Visits is the first listed.

NCT05777473 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05777473 about?

NCT05777473 is a clinical study titled "Tipping Point: Using Social Network Theory to Accelerate Scale and Impact". This study will assess the nature and impact of social norms and networks to promote FP (Family Planning) intervention effects among low parity, married adolescent and young women in the Maradi region of Niger. Research activities will be layered on top of the USAID-funded Kulawa FP program that see...

What is the current status of trial NCT05777473?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,825 participants. The study started on 2020-12-01. Estimated completion is 2025-05-01.

What conditions does trial NCT05777473 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT05777473?

The interventions under investigation include: Household Visits (BEHAVIORAL), Small Groups (BEHAVIORAL), Adopt-a-Friend (BEHAVIORAL).

Who is sponsoring clinical trial NCT05777473?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05777473 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05777473's enrollment target sits among peer trials

3,825 1st of 72 higher than 72 of 72 other Contraception trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07087613 · 3,850 participants

    Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

  • NCT04573660 · 3,784 participants

    Abbott Vascular Medical Device Registry

  • NCT06172660 · 3,750 participants

    Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

  • NCT06298253 · 3,750 participants · NA

    Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05777473, the US trial registry maintained by the National Library of Medicine. NCT05777473 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.